GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Dermavant Eyes Second Vtama Indication with Topline Atopic Dermatitis Results
2023-03-15
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Praxis Stock Hits All-Time Low After Phase 2 Tremor Data Released
2023-03-06
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
Genentech Takes Biogen to Court Over Stockpiled Multiple Sclerosis Drug Royalties
2023-03-01
FDA Approves Sanofi and Sobi’s Once-Weekly Hemophilia A Med
2023-02-23
Dutch Pharmaceutical Watchdog Organization Sues Abbvie over Humira Pricing
2023-02-22
Travere Snags Accelerated Approval for First Non-Immunosuppressive IgAN Therapy
2023-02-19
HHS To Test Three New Models to Lower Drug Prices
2023-02-17
Bloomberg Blasts GSK Over Handling of Zantac’s Cancer Risks
2023-02-15
FDA Slaps Refusal to File Letter on Soligenix’s Photodynamic Cancer Therapy Application
2023-02-14
Biocon and Viatris Hit Another FDA Wall with Avastin Biosimilar
2023-02-13
U.S. Records Spike in Positive Norovirus Cases Among Seasonal Spread
2023-02-12
1 2 3 13
Scroll to Top